Sartorius Stedim Biotech Future Growth
Future criteria checks 4/6
Sartorius Stedim Biotech is forecast to grow earnings and revenue by 31.9% and 10.5% per annum respectively. EPS is expected to grow by 31.6% per annum. Return on equity is forecast to be 13.7% in 3 years.
Key information
31.9%
Earnings growth rate
31.6%
EPS growth rate
| Life Sciences earnings growth | 26.4% |
| Revenue growth rate | 10.5% |
| Future return on equity | 13.7% |
| Analyst coverage | Good |
| Last updated | 23 Oct 2024 |
Recent future growth updates
Sartorius Stedim Biotech S.A. Just Missed Earnings - But Analysts Have Updated Their Models
Jul 21
Sartorius Stedim Biotech S.A. Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next
Apr 21Recent updates
Sartorius Stedim Biotech's (EPA:DIM) Weak Earnings May Only Reveal A Part Of The Whole Picture
Oct 25Sartorius Stedim Biotech S.A.'s (EPA:DIM) Share Price Not Quite Adding Up
Oct 15Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?
Aug 11Sartorius Stedim Biotech S.A. Just Missed Earnings - But Analysts Have Updated Their Models
Jul 21Estimating The Fair Value Of Sartorius Stedim Biotech S.A. (EPA:DIM)
Jul 12Sartorius Stedim Biotech (EPA:DIM) Has A Somewhat Strained Balance Sheet
May 13Sartorius Stedim Biotech S.A. Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next
Apr 21With A 26% Price Drop For Sartorius Stedim Biotech S.A. (EPA:DIM) You'll Still Get What You Pay For
Apr 20Weak Statutory Earnings May Not Tell The Whole Story For Sartorius Stedim Biotech (EPA:DIM)
Feb 19Sartorius Stedim Biotech S.A.'s (EPA:DIM) Popularity With Investors Is Clear
Dec 22Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?
Dec 01Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?
Nov 10Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?
Aug 23Sartorius Stedim Biotech (EPA:DIM) Seems To Use Debt Quite Sensibly
May 25Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Is Well Worth Watching
May 09Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?
Apr 23Here's Why Sartorius Stedim Biotech (EPA:DIM) Can Manage Its Debt Responsibly
Feb 07Does Sartorius Stedim Biotech (EPA:DIM) Deserve A Spot On Your Watchlist?
Jan 20Sartorius Stedim Biotech (EPA:DIM) Has A Pretty Healthy Balance Sheet
Nov 09Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Might Deserve Your Attention Today
Oct 20Estimating The Fair Value Of Sartorius Stedim Biotech S.A. (EPA:DIM)
Oct 03We Think Sartorius Stedim Biotech (EPA:DIM) Can Stay On Top Of Its Debt
Jul 26Do Sartorius Stedim Biotech's (EPA:DIM) Earnings Warrant Your Attention?
Jul 09Is Sartorius Stedim Biotech S.A. (EPA:DIM) Expensive For A Reason? A Look At Its Intrinsic Value
Jun 21Sartorius Stedim Biotech (EPA:DIM) Could Easily Take On More Debt
Apr 21Here's Why I Think Sartorius Stedim Biotech (EPA:DIM) Is An Interesting Stock
Apr 03We Like Sartorius Stedim Biotech's (EPA:DIM) Earnings For More Than Just Statutory Profit
Feb 24Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 3,357 | 447 | 410 | 840 | 12 |
| 12/31/2025 | 3,003 | 340 | 333 | 748 | 12 |
| 12/31/2024 | 2,772 | 212 | 303 | 672 | 12 |
| 9/30/2024 | 2,736 | 161 | 504 | 866 | N/A |
| 6/30/2024 | 2,747 | 170 | 305 | 706 | N/A |
| 3/31/2024 | 2,716 | 255 | 169 | 636 | N/A |
| 12/31/2023 | 2,776 | 310 | 273 | 746 | N/A |
| 9/30/2023 | 2,959 | 460 | 113 | 625 | N/A |
| 6/30/2023 | 3,170 | 635 | 162 | 675 | N/A |
| 3/31/2023 | 3,356 | 717 | 137 | 606 | N/A |
| 12/31/2022 | 3,493 | 876 | 182 | 612 | N/A |
| 9/30/2022 | 3,381 | 681 | 125 | 552 | N/A |
| 6/30/2022 | 3,259 | 625 | 193 | 584 | N/A |
| 3/31/2022 | 3,094 | 559 | 322 | 661 | N/A |
| 12/31/2021 | 2,887 | 414 | 378 | 702 | N/A |
| 9/30/2021 | 2,639 | 523 | 355 | 623 | N/A |
| 6/30/2021 | 2,393 | 469 | 367 | 590 | N/A |
| 3/31/2021 | 2,143 | 398 | 310 | 506 | N/A |
| 12/31/2020 | 1,910 | 336 | 258 | 417 | N/A |
| 9/30/2020 | 1,743 | 299 | 299 | 414 | N/A |
| 6/30/2020 | 1,600 | 255 | 243 | 365 | N/A |
| 3/31/2020 | 1,520 | 254 | 216 | 345 | N/A |
| 12/31/2019 | 1,441 | 235 | 174 | 310 | N/A |
| 9/30/2019 | 1,393 | 247 | 142 | 291 | N/A |
| 6/30/2019 | 1,336 | 238 | 21 | 261 | N/A |
| 3/31/2019 | 1,274 | 223 | 88 | 270 | N/A |
| 12/31/2018 | 1,212 | 208 | 51 | 227 | N/A |
| 9/30/2018 | 1,172 | 185 | 57 | 226 | N/A |
| 6/30/2018 | 1,121 | 173 | N/A | 225 | N/A |
| 3/31/2018 | 1,093 | 162 | N/A | 196 | N/A |
| 12/31/2017 | 1,081 | 161 | N/A | 175 | N/A |
| 9/30/2017 | 1,073 | 151 | N/A | 165 | N/A |
| 6/30/2017 | 1,089 | 157 | N/A | 169 | N/A |
| 3/31/2017 | 1,075 | 157 | N/A | 146 | N/A |
| 12/31/2016 | 1,052 | 154 | N/A | 157 | N/A |
| 9/30/2016 | 1,009 | 145 | N/A | 146 | N/A |
| 6/30/2016 | 971 | 142 | N/A | 129 | N/A |
| 3/31/2016 | 926 | 136 | N/A | 155 | N/A |
| 12/31/2015 | 884 | 118 | N/A | 143 | N/A |
| 9/30/2015 | 850 | 111 | N/A | 150 | N/A |
| 6/30/2015 | 781 | 89 | N/A | 128 | N/A |
| 3/31/2015 | 734 | 76 | N/A | 113 | N/A |
| 12/31/2014 | 684 | 72 | N/A | 111 | N/A |
| 9/30/2014 | 646 | 71 | N/A | 93 | N/A |
| 6/30/2014 | 620 | 67 | N/A | 110 | N/A |
| 3/31/2014 | 604 | 68 | N/A | 97 | N/A |
| 12/31/2013 | 588 | 66 | N/A | 90 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DIM's forecast earnings growth (31.9% per year) is above the savings rate (1.4%).
Earnings vs Market: DIM's earnings (31.9% per year) are forecast to grow faster than the French market (12.4% per year).
High Growth Earnings: DIM's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: DIM's revenue (10.5% per year) is forecast to grow faster than the French market (5.6% per year).
High Growth Revenue: DIM's revenue (10.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: DIM's Return on Equity is forecast to be low in 3 years time (13.7%).